# EDGAR Filing Document

**Accession Number:** 0001385280
**File Stem:** 0000950170-23-004234
**Filing Date:** 2023-2
**Character Count:** 27475
**Document Hash:** 7524b483f547e94567e73e9dbe86b713
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000950170-23-004234.hdr.sgml**: 20230224

**ACCESSION NUMBER**: 0000950170-23-004234

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 14

**CONFORMED PERIOD OF REPORT**: 20230224

**ITEM INFORMATION**: Results of Operations and Financial Condition

**ITEM INFORMATION**: Regulation FD Disclosure

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20230224

**DATE AS OF CHANGE**: 20230224

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Cinemark Holdings, Inc.
- **CENTRAL INDEX KEY:** 0001385280
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-MOTION PICTURE THEATERS [7830]
- **IRS NUMBER:** 205490327
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-33401
- **FILM NUMBER:** 23662283

**BUSINESS ADDRESS:**
- **STREET 1:** 3900 DALLAS PARKWAY
- **CITY:** PLANO
- **STATE:** TX
- **ZIP:** 75093
- **BUSINESS PHONE:** (972) 665-1000

**MAIL ADDRESS:**
- **STREET 1:** 3900 DALLAS PARKWAY
- **CITY:** PLANO
- **STATE:** TX
- **ZIP:** 75093

?xml version="1.0" encoding="ASCII"? 8-K

**UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549**

------

**FORM** 8-K

------

**CURRENT REPORT**

**Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934**

**Date of Report (Date of earliest event reported):** February 24, 2023<br>

------

CINEMARK HOLDINGS, INC.

**(Exact name of Registrant as Specified in Its Charter)**

------

---

| | | |
|:---|:---|:---|
| Delaware | 001-33401 | 20-5490327 |
| **(State or Other Jurisdiction<br>of Incorporation)** | **(Commission File Number)** | **(IRS Employer<br>Identification No.)** |
| 3900 Dallas Parkway |  |  |
| Plano**,** Texas |  | 75093 |
| **(Address of Principal Executive Offices)** |  | **(Zip Code)** |

---

**Registrant's Telephone Number, Including Area Code:** 972 665-1000<br>

**(Former Name or Former Address, if Changed Since Last Report)**

------

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

**Securities registered pursuant to Section 12(b) of the Act:**

---

| | |
|:---|:---|
| **Title of each class** | **Name of each exchange on which registered** |
| Common Stock, par value $.001 per share<br> CNK | The New York Stock Exchange |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

------

**Item 2.02 Results of Operations and Financial Condition.**

On February 24, 2023, we announced our financial results for the forth quarter and year ended December 31, 2022. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and incorporated herein by reference.

**Item 7.01 Regulation FD Disclosure.**

On February 24, 2023, we announced our financial results for the fourth quarter and year ended December 31, 2022. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and incorporated herein by reference.

**Item 9.01 Financial Statements and Exhibits.**

(d) Exhibits.

---

| | |
|:---|:---|
| **Exhibit**<br>**No.** | **<u>Exhibit Description</u>** |
| 99.1 | [<u>Earnings press release dated February 24, 2023</u>](cnk-ex99_1.htm) |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) |

---

The information furnished pursuant to Items 2.02 and 7.01 of this Current Report on Form 8-K, including the exhibits, shall not be deemed to be incorporated by reference into any of our filings with the SEC under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in any such filing, and shall not be deemed to be "filed" with the SEC under the Securities Exchange Act of 1934, as amended.

------

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;CINEMARK HOLDINGS, INC. | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;CINEMARK HOLDINGS, INC. |
| By: | /s/ Michael D. Cavalier |
| Name: | Michael D. Cavalier |
| Title: | Executive Vice President - General Counsel |

---

Date: February 24, 2023

------

## Ex-99

**Exhibit 99.1**

![img115247109_0.jpg](img115247109_0.jpg)

**CINEMARK HOLDINGS, INC. REPORTS FOURTH QUARTER AND FULL YEAR 2022 RESULTS**

**Total revenue of $2.5B increased 63% versus 2021, resulting in $136M of positive cash flow from operations and $25M of free cash flow for the full year**

**Full year box office results outpaced industry recovery by approximately 500 basis points versus 2019**

Plano, TX, February 24, 2023 – Cinemark Holdings, Inc. (NYSE: CNK), one of the largest motion picture exhibitors in the world, today reported results for the three and twelve months ended December 31, 2022.

Cinemark Holdings, Inc.'s total revenue for the three months ended December 31, 2022 decreased 10% to $599.7 million compared with $666.7 million for the three months ended December 31, 2021. For the three months ended December 31, 2022, admissions revenue was $304.6 million and concession revenue was $225.7 million, driven by attendance of 39.2 million patrons. Average ticket price was $7.77 and concession revenue per patron was $5.76.

Net loss attributable to Cinemark Holdings, Inc. for the three months ended December 31, 2022 was $(99.3) million compared with net income of $5.7 million for the three months ended December 31, 2021. Diluted loss per share for the three months ended December 31, 2022 was $(0.82) compared with diluted earnings per share of $0.05 for the three months ended December 31, 2021.

Adjusted EBITDA for the three months ended December 31, 2022 was $73.5 million compared with $139.4 million for the three months ended December 31, 2021. Reconciliations of non-GAAP financial measures are provided in the financial schedules accompanying this press release and at https://ir.cinemark.com.

"This past year represented another positive step forward for the theatrical exhibition industry's recovery from the pandemic," stated Sean Gamble, Cinemark's President & CEO. "Sustained consumer enthusiasm to view movies and events in an immersive, larger-than-life, theatrical setting was validated time and again throughout 2022 across all genres, audience segments, and periods of the year."

"For Cinemark, 2022 marked a series of important results and milestones that exemplified our improved financial stability and outsized recovery relative to our industry and peers. Of particular significance, we ended the year with a sizable increase in worldwide revenue and Adjusted EBITDA, generating $25M of positive free cash flow."

"We remain highly optimistic about the many opportunities that lie ahead for our company, and as our industry continues to recover, Cinemark is poised to excel on account of our advantaged financial position, industry-leading operating capabilities, and sensational team."

Cinemark Holdings, Inc.'s total revenue for the twelve months ended December 31, 2022 increased 62.5% to $2,454.7 million compared with $1,510.5 million for the twelve months ended December 31, 2021. For the twelve months ended December 31, 2022, admissions revenue was $1,246.9 million and concession revenue was $938.3 million, driven by attendance of 172.7 million patrons. Average ticket price was $7.22 and concession revenue per patron was $5.43.

Net loss attributable to Cinemark Holdings, Inc. for the twelve months ended December 31, 2022 was $(271.2) million compared with a net loss of $(422.8) million for the twelve months ended December 31, 2021. Diluted loss per share for the twelve months ended December 31, 2022 was $(2.26) compared with diluted loss per share of $(3.55) for the twelve months ended December 31, 2021.

Adjusted EBITDA for the twelve months ended December 31, 2022 was $336.5 million compared with $80.0 million for the twelve months ended December 31, 2021. Reconciliations of non-GAAP financial measures are provided in the financial schedules accompanying this press release and at https://ir.cinemark.com.

As of December 31, 2022, the Company's aggregate screen count was 5,847, and the Company had commitments to open one new theatre and 4 screens during the remainder of 2023 and 6 new theatres and 51 screens subsequent to 2023.

------

**<u>Webcast – Today at 8:30 AM ET</u>**

**Live Webcast/Replay:** Available live at https://ir.cinemark.com. A replay will be available following the call and archived for a limited time.

**About Cinemark Holdings, Inc.**

Headquartered in Plano, TX, Cinemark (NYSE: CNK) is one of the largest and most influential movie theatre companies in the world. Cinemark's circuit, comprised of various brands that also include Century, Tinseltown and Rave, as of December 31, 2022 operated 518 theatres with 5,847 screens in 42 states domestically and 15 countries throughout South and Central America. Cinemark consistently provides an extraordinary guest experience from the initial ticket purchase to the closing credits, including Movie Club, the first U.S. exhibitor-launched subscription program; the highest Luxury Lounger recliner seat penetration among the major players; XD - the No. 1 exhibitor-brand premium large format; and expansive food and beverage options to further enhance the moviegoing experience. For more information go to https://ir.cinemark.com.

**<u>Financial Contact</u>:**

Chanda Brashears – 972-665-1671 or cbrashears@cinemark.com

**<u>Media Contact:</u>**

Julia McCartha – 972-665-1322 or pr@cinemark.com

**Forward-looking Statements**

This press release includes "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on information currently available as well as management's assumptions and beliefs today. These statements are subject to numerous risks and uncertainties that could cause actual results to differ materially from the results expressed or implied by the statements, and investors should not place undue reliance on them. Risks and uncertainties that could cause actual results to differ materially from such statements include:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•future revenues, expenses and profitability;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•currency exchange rate and inflationary impacts;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•the future development and expected growth of our business;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•projected capital expenditures;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•access to capital resources;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•attendance at movies generally or in any of the markets in which we operate;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•the number and diversity of popular movies released, the length of exclusive theatrical release windows, and our ability to successfully license and exhibit popular films;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•national and international growth in our industry;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•competition from other exhibitors, alternative forms of entertainment and content delivery via streaming and other formats;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•determinations in lawsuits in which we are a party; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•the impact of the COVID-19 pandemic on us and the motion picture exhibition industry.

You can identify forward-looking statements by the use of words such as "may," "should," "could," "estimates," "predicts," "potential," "continue," "anticipates," "believes," "plans," "expects," "future" and "intends" and similar expressions which are intended to identify forward-looking statements. These statements are not guarantees of future performance and are subject to risks, uncertainties and other factors, some of which are beyond our control and difficult to predict. Such risks and uncertainties could cause actual results to differ materially from those expressed or forecasted in the forward-looking statements. In evaluating forward-looking statements, you should carefully consider the risks and uncertainties described in the "Risk Factors" section or other sections in Cinemark Holdings, Inc.'s Annual Report on Form 10-K filed February 24, 2023. All forward-looking statements attributable to us or persons acting on our behalf are expressly qualified in their entirety by these cautionary statements and risk factors. Forward-looking statements contained in this press release reflect our view only as of the date of this press release. We undertake no obligation, other than as required by law, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

------

**Cinemark Holdings, Inc.**

**Financial and Operating Summary**

(unaudited, in millions, except per share amounts)

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three Months Ended** | **Three Months Ended** | **Twelve Months Ended** | **Twelve Months Ended** |
|  | **December 31,** | **December 31,** | **December 31,** | **December 31,** |
|  | **2022** | **2021** | **2022** | **2021** |
| **Statement of income (loss) data:** |  |  |  |  |
| Revenue |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Admissions | $304.6 | $344.9 | $1246.9 | $780.0 |
| &nbsp;&nbsp;&nbsp;Concession | 225.7 | 248.2 | 938.3 | 561.7 |
| &nbsp;&nbsp;&nbsp;Other | 69.4 | 73.6 | 269.5 | 168.8 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total Revenue | 599.7 | 666.7 | 2454.7 | 1510.5 |
| Cost of operations |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Film rentals and advertising | 173.3 | 198.2 | 704.4 | 415.0 |
| &nbsp;&nbsp;&nbsp;Concession supplies | 40.5 | 43.7 | 169.3 | 97.9 |
| &nbsp;&nbsp;&nbsp;Salaries and wages | 95.7 | 83.7 | 372.7 | 232.9 |
| &nbsp;&nbsp;&nbsp;Facility lease expense | 77.1 | 79.2 | 308.3 | 280.0 |
| &nbsp;&nbsp;&nbsp;Utilities and other | 103.4 | 90.8 | 407.2 | 282.9 |
| &nbsp;&nbsp;&nbsp;General and administrative expenses | 43.6 | 49.3 | 177.6 | 161.1 |
| &nbsp;&nbsp;&nbsp;Depreciation and amortization | 57.2 | 63.1 | 238.2 | 265.4 |
| &nbsp;&nbsp;&nbsp;Impairment of long-lived assets | 66.6 | 13.3 | 174.1 | 20.8 |
| &nbsp;&nbsp;&nbsp;Restructuring costs | (0.3) | 0.3 | (0.5) | (1.0) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(Gain) loss on disposal of assets and other | (0.4) | 0.2 | (6.8) | 8.0 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total cost of operations | 656.7 | 621.8 | 2544.5 | 1763.0 |
| Operating income (loss) | (57.0) | 44.9 | (89.8) | (252.5) |
| &nbsp;&nbsp;&nbsp;Interest expense | (40.7) | (38.1) | (155.3) | (149.7) |
| &nbsp;&nbsp;&nbsp;Interest income | 9.3 | 1.1 | 20.4 | 6.4 |
| &nbsp;&nbsp;&nbsp;Loss on extinguishment of debt |  |  |  | (6.5) |
| &nbsp;&nbsp;&nbsp;Foreign currency exchange loss | (6.2) | (0.4) | (11.5) | (1.3) |
| &nbsp;&nbsp;&nbsp;Distributions from NCM |  |  |  | 0.1 |
| &nbsp;&nbsp;&nbsp;Cash distributions from DCIP |  | 6.6 | 3.7 | 13.1 |
| &nbsp;&nbsp;&nbsp;Interest expense - NCM | (5.7) | (5.9) | (23.2) | (23.6) |
| &nbsp;&nbsp;&nbsp;Equity in loss of affiliates | (1.8) | (3.0) | (9.3) | (25.0) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total other expense | (45.1) | (39.7) | (175.2) | (186.5) |
| Income (loss) before income taxes | (102.1) | 5.2 | (265.0) | (439.0) |
| &nbsp;&nbsp;&nbsp;Income tax (benefit) expense | (3.3) | (1.2) | 3.0 | (16.8) |
| Net income (loss) | (98.8) | $6.4 | $(268.0) | $(422.2) |
| &nbsp;&nbsp;&nbsp;Less: Net income attributable to noncontrolling interests | 0.5 | 0.7 | 3.2 | 0.6 |
| Net income (loss) attributable to Cinemark Holdings, Inc. | (99.3) | $5.7 | $(271.2) | $(422.8) |
| Earnings (loss) per share attributable to Cinemark Holdings, Inc.'s common stockholders |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Basic | $(0.82) | $0.05 | $(2.26) | $(3.55) |
| &nbsp;&nbsp;&nbsp;Diluted | $(0.82) | $0.05 | $(2.26) | $(3.55) |
| Diluted weighted average shares outstanding | 118.5 | 117.6 | 118.2 | 117.3 |

---

------

**Other Operating Data**

(unaudited, in millions)

---

| | | |
|:---|:---|:---|
|  | **As of December 31,** | **As of December 31,** |
|  | **2022** | **2021** |
| **Balance sheet data:** |  |  |
| &nbsp;&nbsp;Cash and cash equivalents | $674.5 | $707.3 |
| &nbsp;&nbsp;Theatre properties and equipment, net | $1232.1 | $1382.9 |
| &nbsp;&nbsp;Total assets | $4817.7 | $5230.6 |
| &nbsp;&nbsp;Long-term debt, net of unamortized debt issuance costs | $2484.7 | $2500.6 |
| &nbsp;&nbsp;Equity | $119.5 | $334.5 |

---

---

| | | |
|:---|:---|:---|
|  | **Year Ended December 31,** | **Year Ended December 31,** |
|  | **2022** | **2021** |
| **Cash flows provided by (used for):** |  |  |
| &nbsp;&nbsp;Operating activities (1) | $136.0 | $166.2 |
| &nbsp;&nbsp;Investing activities | $(96.3) | $(89.3) |
| &nbsp;&nbsp;Financing activities | $(52.2) | $(19.9) |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)We define free cash flow as cash flow provided by operating activities less capital expenditures. A reconciliation of cash flow provided by operating activities to free cash flow is provided below:

---

| | | |
|:---|:---|:---|
|  | **Year Ended December 31,** | **Year Ended December 31,** |
|  | **2022** | **2021** |
| **Reconciliation of free cash flow:** |  |  |
| &nbsp;&nbsp;Cash flows provided by operating activities | $136.0 | $166.2 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Less: Capital expenditures | (110.7) | (95.5) |
| &nbsp;&nbsp;Free cash flow | $25.3 | $70.7 |

---

**Segment Information**

(unaudited, in millions, except per patron data)

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **U.S. Operating Segment** | **U.S. Operating Segment** | **International Operating Segment** | **International Operating Segment** | **International Operating Segment** | **Consolidated** | **Consolidated** |
|  | **Three Months Ended<br>December 31,** | **Three Months Ended<br>December 31,** | **Three Months Ended<br>December 31,** | **Three Months Ended<br>December 31,** | **Constant <br>Currency ¹** | **Three Months Ended<br>December 31,** | **Three Months Ended<br>December 31,** |
|  | **2022** | **2021** | **2022** | **2021** | **2022** | **2022** | **2021** |
| **Revenue and Attendance** |  |  |  |  |  |  |  |
| Admissions revenue | $251.1 | $287.3 | $53.5 | $57.6 | $59.3 | $304.6 | $344.9 |
| Concession revenue | 186.5 | 207.8 | 39.2 | 40.4 | 44.0 | 225.7 | 248.2 |
| Other revenue | 48.1 | 56.6 | 21.3 | 17.0 | 23.4 | 69.4 | 73.6 |
| &nbsp;&nbsp;Total revenue | $485.7 | $551.7 | $114.0 | $115.0 | $126.7 | $599.7 | $666.7 |
| Attendance | 25.1 | 31.2 | 14.1 | 16.9 |  | 39.2 | 48.1 |
| Average ticket price | $10.00 | $9.21 | $3.79 | $3.41 | $4.21 | $7.77 | $7.17 |
| Concession revenue per patron | $7.43 | $6.66 | $2.78 | $2.39 | $3.12 | $5.76 | $5.16 |
| **Cost of Operations** |  |  |  |  |  |  |  |
| Film rentals and advertising | $145.4 | $168.5 | $27.9 | $29.7 | $31.1 | $173.3 | $198.2 |
| Concession supplies | 31.6 | 34.9 | 8.9 | 8.8 | 10.0 | 40.5 | 43.7 |
| Salaries and wages | 81.3 | 71.8 | 14.4 | 11.9 | 16.5 | 95.7 | 83.7 |
| Facility lease expense | 62.5 | 64.5 | 14.6 | 14.7 | 16.0 | 77.1 | 79.2 |
| Utilities and other | 78.9 | 71.1 | 24.5 | 19.7 | 27.2 | 103.4 | 90.8 |

---

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| **`** | **U.S. Operating Segment** | **U.S. Operating Segment** | **International Operating Segment** | **International Operating Segment** | **International Operating Segment** | **Consolidated** | **Consolidated** |
|  | **Twelve Months Ended<br>December 31,** | **Twelve Months Ended<br>December 31,** | **Twelve Months Ended<br>December 31,** | **Twelve Months Ended<br>December 31,** | **Constant <br>Currency ¹** | **Twelve Months Ended<br>December 31,** | **Twelve Months Ended<br>December 31,** |
|  | **2022** | **2021** | **2022** | **2021** | **2022** | **2022** | **2021** |
| **Revenue and Attendance** |  |  |  |  |  |  |  |
| Admissions revenue | $1010.2 | $671.7 | $236.7 | $108.3 | $258.8 | $1246.9 | $780.0 |
| Concession revenue | 763.0 | 482.8 | 175.3 | 78.9 | 193.7 | 938.3 | 561.7 |
| Other revenue | 197.0 | 139.1 | 72.5 | 29.7 | 78.7 | 269.5 | 168.8 |
| &nbsp;&nbsp;Total revenue | $1970.2 | $1293.6 | $484.5 | $216.9 | $531.2 | $2454.7 | $1510.5 |
| Attendance | 109.3 | 73.0 | 63.4 | 32.6 |  | 172.7 | 105.6 |
| Average ticket price | $9.24 | $9.20 | $3.73 | $3.32 | $4.08 | $7.22 | $7.39 |
| Concession revenue per patron | $6.98 | $6.61 | $2.76 | $2.42 | $3.06 | $5.43 | $5.32 |
| **Cost of Operations** |  |  |  |  |  |  |  |
| Film rentals and advertising | $584.4 | $360.0 | $120.0 | $55.0 | $131.7 | $704.4 | $415.0 |
| Concession supplies | 130.5 | 79.5 | 38.8 | 18.4 | 42.9 | 169.3 | 97.9 |
| Salaries and wages | 314.7 | 198.2 | 58.0 | 34.7 | 64.0 | 372.7 | 232.9 |
| Facility lease expense | 250.1 | 242.2 | 58.2 | 37.8 | 62.8 | 308.3 | 280.0 |
| Utilities and other | 313.7 | 232.1 | 93.5 | 50.8 | 101.2 | 407.2 | 282.9 |

---

(1)Constant currency amounts, which are non-GAAP measurements, were calculated using the average exchange rate for the corresponding month for 2021. We translate the results of our international operating segment from local currencies into U.S. dollars using currency rates in effect at different points in time in accordance with U.S. GAAP. Significant changes in foreign currency exchange rates from one period to the next can result in meaningful variations in reported results. We are providing constant currency amounts for our international operating segment to present a period-to-period comparison of business performance that excludes the impact of foreign currency fluctuations.

------

**Other Segment Information**

(unaudited, in millions)

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three Months Ended <br>December 31,** | **Three Months Ended <br>December 31,** | **Twelve Months Ended <br>December 31,** | **Twelve Months Ended <br>December 31,** |
|  | **2022** | **2021** | **2022** | **2021** |
| **Adjusted EBITDA (1)** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;U.S. | $59.5 | $115.9 | $255.7 | $84.2 |
| &nbsp;&nbsp;&nbsp;&nbsp;International | 14.0 | 23.5 | 80.8 | (4.2) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total Adjusted EBITDA | $73.5 | $139.4 | $336.5 | $80.0 |
| **Capital expenditures** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;U.S. | $36.5 | $30.8 | $87.2 | $78.3 |
| &nbsp;&nbsp;&nbsp;&nbsp;International | 8.9 | 7.5 | 23.5 | 17.2 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total capital expenditures | $45.4 | $38.3 | $110.7 | $95.5 |

---

(1)Adjusted EBITDA represents net income (loss) before income taxes, depreciation and amortization expense and other items, as calculated below. Adjusted EBITDA is a non-GAAP financial measure commonly used in our industry and should not be construed as an alternative to net income as an indicator of operating performance or as an alternative to cash flow provided by operating activities as a measure of liquidity (as determined in accordance with GAAP). Adjusted EBITDA may not be comparable to similarly titled measures reported by other companies. We have included Adjusted EBITDA because we believe it provides management and investors with additional information to measure our performance and liquidity, estimate our value and evaluate our ability to service debt. In addition, we use Adjusted EBITDA for incentive compensation purposes. A reconciliation of net income (loss) to Adjusted EBITDA is provided below.

**Reconciliation of Adjusted EBITDA**

(unaudited, in millions)

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three Months Ended December 31,** | **Three Months Ended December 31,** | **Twelve Months Ended December 31,** | **Twelve Months Ended December 31,** |
|  | **2022** | **2021** | **2022** | **2021** |
| Net income (loss) | $(98.8) | $6.4 | $(268.0) | $(422.2) |
| Add (deduct): |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Income taxes | (3.3) | (1.2) | 3.0 | (16.8) |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest expense (1) | 40.7 | 38.1 | 155.3 | 149.7 |
| &nbsp;&nbsp;&nbsp;&nbsp;Loss on extinguishment of debt |  |  |  | 6.5 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other expense, net (2) | 4.4 | 8.2 | 23.6 | 43.5 |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash distributions from other equity investees (3) | 5.4 |  | 6.9 | 0.2 |
| &nbsp;&nbsp;&nbsp;&nbsp;Depreciation and amortization | 57.2 | 63.1 | 238.2 | 265.4 |
| &nbsp;&nbsp;&nbsp;&nbsp;Impairment of long-lived assets | 66.6 | 13.3 | 174.1 | 20.8 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(Gain) loss on disposal of assets and other | (0.4) | 0.2 | (6.8) | 8.0 |
| &nbsp;&nbsp;&nbsp;&nbsp;Restructuring charges | (0.3) | 0.3 | (0.5) | (1.0) |
| &nbsp;&nbsp;&nbsp;&nbsp;Non-cash rent | (3.3) | (1.7) | (10.8) | (3.4) |
| &nbsp;&nbsp;&nbsp;&nbsp;Share based awards compensation expense (4) | 5.3 | 12.7 | 21.5 | 29.3 |
| Adjusted EBITDA | $73.5 | 139.4 | $336.5 | $80.0 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)Includes amortization of debt issuance costs and amortization of accumulated losses for amended swap agreements.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2)Includes interest income, foreign currency exchange gain (loss), equity in loss of affiliates and interest expense - NCM and excludes distributions from NCM and DCIP.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3)Includes cash distributions received from equity investees that were recorded as a reduction of the respective investment balances. These distributions are reported entirely within the U.S. operating segment.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(4)Non-cash expense included in general and administrative expenses.

------